Cochlear expands into ResMed’s field of sleep apnea.
Hearing implant maker Cochlear (ASX:COH) has expanded beyond its hearing speciality into the field of sleep, an area now dominated by fellow Australian manufacturer ResMed. Cochlear invested $21 million in a capital raising by Nyxoah S.A., a Belgian medical device company commercialising a nerve stimulation implant for the treatment of Obstructive Sleep Apnea. Jan Janssen,…